Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of alfentanil, sufentanil, and fentanyl on cardiac function in elderly patients with chronic coronary syndrome
ChiCTR2100054925Phase 4Recruiting
- Sponsor
- The 2nd Affiliated Hospital of Chongqing Medical University
- Start
- Dec 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of alfentanil, sufentanil and fentanyl in Chronic Coronary Syndrome (CCS) (3 arms), sponsored by The 2nd Affiliated Hospital of Chongqing Medical University. Primary endpoint: Global longitudinal strain. Started Dec 2021; status: recruiting.
02
Drugs
alfentanilsufentanilfentanyl
03
Conditions
Chronic Coronary Syndrome (CCS)
Beyond the preview
Go deeper on ChiCTR2100054925.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100054925.